THE REAL PREVALENCE OF EROSIVE ESOPHAGITIS AND BARRETT'S ESOPHAGUS IN SYSTEMIC SCLERODERMA: DATA FROM 12-MONTHS PROSPECTIVE STUDY
https://doi.org/10.14412/1995-4484-2012-1182
Abstract
References
1. <div><p>Ревматология. Клинические рекомендации. Под ред. Е.Л. Насонова. М.: ГЭОТАР-Медиа, 2010; 752 с.</p><p>Ebert E. Esophageal disease in progressive systemic sclerosis. Curr Treat Options Gastroenterol 2008; 11(1): 64—9.</p><p>Ntoumazios S., Voulgari P., Potsis K. et al. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthr Rheum 2006; 36(3): 173—81.</p><p>Kowal-Bielecka O., Landewe R., Avouac J. et al. EULAR recommendation for the treatment of systemic sclerosis: a report from the EULAR scleroderma trials and research group (EUROSTAR). Ann Rheum Dis 2009; 68(50): 620—9.</p><p>Wipff J., Coriat R., Masciocchi M. et al. Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study. Rheumatology (Oxford) 2011, Mar 16 [Epub. ahead of print]</p><p>Rabeneck L., Cook K., Wristers K. et al. SODA (severity of dyspepsia assessment): a new effective outcome measure for dyspepsia-related health. J Clin Epidemiol 2001; 54(8): 755—65.</p><p>Roberts D., Miner P. Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease. Drug Healthc Patient Saf 2011; 3: 1—8.</p><p>Лазебник Л.Б., Дроздов В.Н., Ким В.А. Эффективность фамотидина в профилактике НПВП-гастропатий. Результаты российского многоцентрового исследования ЗАСЛОН-1 (защита слизистой оболочки желудка от нестероидных противовоспалительных препаратов). Экпер. клин. гастроэнтерол. 2009; 2: 3—9.</p><p>Калинин А.В. Гастроэзофагеальная рефлюксная болезнь: диагностика, терапия и профилактика. Фарматека 2003; 7: 23—9.</p><p>Paull A., Trier J., Dalton M. et al. The histologic spectrum of Barrett's esophagus. N Engl J Med 1976; 295: 476—80.</p><p>Kilgore S., Ormsby A., Gramlich T. The gastric cardia: fact or fiction? Amer J Gastroenterol 2000; 95: 91—4.</p><p>Quiglet E. The gastroesophageal junction revision: Perspectives in GERD. World Gastroenterol News 2000; 5: 25—8.</p><p>Weingart V., Allescher H. Non-cardiac chest pain. Dtsch Med Wschr 2010; 135(43): 2135—46.</p><p>Miwa H., Kondo T., Oshima T. et al. Esophageal sensation and esophageal hypersensitivity — overview from bench to bedside. J Neurogastroenterol Motil 2010; 16(4): 353—62.</p><p>Nishimagi E., Tochimoto A., Kawaguchi Y. et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007; 34(10): 2050—5.</p><p>Lahcene M., Oumnia N., Matougui N. et al. Esophageal involvement in scleroderma: clinical, endoscopic, and manometric features. ISRN Rheumatol 2011; doi: 10.5402/2011: 325826.</p><p>Алекперов Р.Т., Каратеев А.Е., Гусева Н.Е Ланзап в лечении склеродермического эзофагита. Науч.-практич. ревматол. 2003; 2: 25—8.</p><p>Marie I., Ducrotte P., Denis P. et al. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24(11—12): 1593—601.</p><p>Каратеев А.Е., Мовсисян М.М., Ананьева Л.П., Раденска-Лоповок С.Г. Патология пищевода при системной склеродермии: данные клинико-эндоскопического обследования. Науч.-практич. ревматол. 2012; 1: 54—9.</p><p>Marie I. Gastrointestinal involvement in systemic sclerosis. Presse Med 2006; 35(12 Pt 2): 1952—65.</p><p>Santos-Navarro R., Mendez-del-Monte R., del Real-Calzada C., Vera-Lastra O. Clinical, endoscopic and manometric findings in the gastroesophageal tract of patients with systemic sclerosis. Rev Med Inst Mex Seguro Soc 2008; 46(5): 503—10.</p><p>Wipff J., Allanore Y., Soussi F. et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthr Rheum 2005; 52(9): 2882—8.</p></div><br />
Review
For citations:
Karateev A.E., Movsisyan M.S., Radenska-Lopovok S.G., Ananyeva L.P. THE REAL PREVALENCE OF EROSIVE ESOPHAGITIS AND BARRETT'S ESOPHAGUS IN SYSTEMIC SCLERODERMA: DATA FROM 12-MONTHS PROSPECTIVE STUDY. Rheumatology Science and Practice. 2012;50(5):51-55. (In Russ.) https://doi.org/10.14412/1995-4484-2012-1182